首页 | 本学科首页   官方微博 | 高级检索  
   检索      

可溶性HLA-A*0203-BSP原核表达载体的构建及其在大肠杆菌中的高效表达
引用本文:贾仟涛,徐丽慧,迟晓云,查庆兵,李丰耀,何贤辉.可溶性HLA-A*0203-BSP原核表达载体的构建及其在大肠杆菌中的高效表达[J].中国生物工程杂志,2006,26(9):5-10.
作者姓名:贾仟涛  徐丽慧  迟晓云  查庆兵  李丰耀  何贤辉
作者单位:暨南大学 生命科学技术学院 组织移植与免疫中心 暨南大学 生命科学技术学院 生物工程研究所 暨南大学 生命科学技术学院 组织移植与免疫中心 暨南大学 生命科学技术学院 组织移植与免疫中心 暨南大学 生命科学技术学院 组织移植与免疫中心 暨南大学 生命科学技术学院 组织移植与免疫中心
摘    要:目的:构建HLA-A*0203重链胞外域羧基端融合生物素化酶BirA底物肽(BSP)的融合蛋白(HLA-A*0203-BSP)的原核表达载体并在大肠杆菌中进行表达。方法:以RT-PCR方法从HLA-A2+ 供者外周血单个核细胞(PBMC)中克隆HLA-A*0203重链基因的cDNA并测序鉴定,然后以PCR方法构建HLA-A*0203-BSP的原核表达载体,在大肠杆菌BL21(DE3)菌株中诱导表达并以免疫印迹鉴定。结果:DNA测序显示,从3名HLA-A2+ 供者PBMC中克隆的cDNA中,只有从供者2获得编码HLA-A*0203重链基因的cDNA。将编码重链胞外域1-276的序列和编码BSP的序列融合,构建HLA-A*0203-BSP融合蛋白的原核表达载体并经测序验证。该融合蛋白在BL21(ED3)中获得高效表达,约占菌体总蛋白的30%;产物相对分子质量约为34 kD,与理论大小一致。Western印迹分析显示融合蛋白完全存在于包涵体中。结论:成功克隆HLA-A*0203重链基因的cDNA,构建HLA-A*0203-BSP融合蛋白的原核表达载体,并在大肠杆菌中获得高效表达,为制备HLA-A*0203四聚体打下基础。

关 键 词:融合蛋白  原核表达  包涵体  人类白细胞抗原  胞外域  
收稿时间:2006-03-15
修稿时间:2006年3月15日

Construction of Prokaryotic Expression Vector for Soluble HLA-A*0203-BSP and Its High Yield Expression in Escherichia coli
JIA Qian-tao,XU Li-hui,CHI Xiao-yun,ZHA Qing-bing,LI Feng-yao,HE Xian-hui.Construction of Prokaryotic Expression Vector for Soluble HLA-A*0203-BSP and Its High Yield Expression in Escherichia coli[J].China Biotechnology,2006,26(9):5-10.
Authors:JIA Qian-tao  XU Li-hui  CHI Xiao-yun  ZHA Qing-bing  LI Feng-yao  HE Xian-hui
Abstract:Objective: To clone the cDNA of HLA-A0203 heavy chain and to construct the prokaryotic expression vector for the ectodomain of HLA-A0203 fused with a BirA substrate peptide (BSP) at its carboxyl terminus ( HLA-A0203-BSP ) and express the recombinant protein in Escherichia coli. Methods: The cDNA for HLA-A0203 heavy chain was cloned by RT-PCR from the PBMC of three HLA-A2~ donors and confirmed by DNA sequencing. DNA fragment encoding HLA-A0203-BSP was amplified by PCR with the sequence-verified cDNA as a template. It was then cloned into pET-3d vector. After confirmed by DNA sequencing once again, the prokaryotic expression vector was transformed into BL21(DE3) strain. The recombinant protein was expressed in E/ coli after IPTG induction. SDS-PAGE and Western blot analyses were employed to detect the expressed fusion protein. Results: DNA sequence analysis showed that the cDNA encoding the heavy chain of HLA -A0203 was cloned from donor 2, which had been confirmed to be HLA-A2~ by flow cytometry. The expression vector for the recombinant HLA-A0203-BSP fusion protein was then constructed and verified by DNA sequencing. SDS-PAGE analysis revealed that the fusion protein was highly expressed in E. coli and accounted for 30% of total bacterial proteins. Furthermore, Western blotting showed that all the recombinant protein existed in the inclusion bodies. The fusion protein had a molecular weight of about 34 kDa, which is in accordance with the theoretical value. Conclusion: The cDNA of HLA-A0203 heavy chain was cloned and the prokaryotic expression vector for the fusion protein of HLA-A0203-BSP was constructed. The recombinant protein was highly expressed as the form of inclusion bodies in E. coli, which would facilitate the preparation of soluble HLA-A0203 tetramer.
Keywords:Human leukocyte antigen Ectodomain Fusion protein Prokaryotic expression Inclusion body
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国生物工程杂志》浏览原始摘要信息
点击此处可从《中国生物工程杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号